Cannabis Effects on Sleep, Circadian Rhythms, and Light Sensitivity in Young Adults
NCT06743373 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180
Last updated 2026-04-06
Summary
The goal of this study is to learn how cannabis use and discontinuation affect sleep, circadian rhythms, and sensitivity to light. The main questions it aims to answer are:
1. Does cannabis use and discontinuation impact sleep drive?
2. Does cannabis use and discontinuation impact light sensitivity and circadian phase?
Conditions
- Cannabis Use
- Sleep
- Circadian Rhythm
Interventions
- BEHAVIORAL
-
Cannabis Discontinuation
Cannabis-using participants will participate in an orientation session with a clinician and asked to abstain from cannabis use for four weeks, using established procedures for abstinence monitoring and reinforcement.
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
collaborator NIH -
University of Pittsburgh
lead OTHER
Principal Investigators
-
Brant P Hasler, PhD · University of Pittsburgh
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 25 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-03-13
- Primary Completion
- 2029-01-31
- Completion
- 2029-04-30
Countries
- United States
Study Locations
More Related Trials
-
Vaporized Cannabis Administration and Co-Administration of Alcohol on Impairment
NCT06293040 ·Status: RECRUITING ·Phase: PHASE1
-
Clinical and Neurobiological Effects of Cannabis Dependence in Young Adults
NCT00656487 ·Status: COMPLETED ·Phase: PHASE2
-
The Role of Sleep in the Treatment of Cannabis Use Disorders
NCT01685073 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Effect of Prescription Medications in Marijuana Users
NCT00893074 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effects of Citicoline on Brain Function and Behavior in Marijuana-Dependent Individuals
NCT00158249 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating Cannabidiol as a Novel Anticraving Medication for Alcohol Use Disorder
NCT06512389 ·Status: RECRUITING ·Phase: PHASE2
-
Reducing Alcohol Use in Depressed Patients
NCT00183079 ·Status: COMPLETED ·Phase: PHASE2
-
Varenicline Treatment for Cannabis Use Disorder
NCT02892110 ·Status: COMPLETED ·Phase: PHASE2
-
The Neural Correlates of Cannabis Use
NCT03104257 ·Status: COMPLETED
-
UH3 Varenicline for Cannabis Use Disorder
NCT03980561 ·Status: COMPLETED ·Phase: PHASE2
-
Repetitive Transcranial Magnetic Stimulation for Cannabis Use Disorder
NCT05859347 ·Status: RECRUITING ·Phase: NA
-
Buspirone Treatment for Marijuana Dependence
NCT00875836 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of a FAAH-Inhibitor to Treat Cannabis Withdrawal
NCT01618656 ·Status: COMPLETED ·Phase: PHASE2
-
D-Cycloserine to Enhance Extinction to Alcohol Cues
NCT01362309 ·Status: COMPLETED ·Phase: NA
-
Cannabidiol in Youth Alcohol Use Disorder
NCT05317546 ·Status: COMPLETED ·Phase: PHASE2
-
A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence
NCT02061293 ·Status: COMPLETED ·Phase: PHASE2
-
Cannabidiol for Alcohol Use Disorder
NCT03904849 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Treatment for Cannabis Withdrawal and Dependence
NCT01611948 ·Status: COMPLETED ·Phase: PHASE2
-
The Impact of Oral Cannabis Administration and Co-Administration of Alcohol on Impairment
NCT04931095 ·Status: COMPLETED ·Phase: PHASE1
-
The Effects of Cannabidiol on the Driving Performance of Healthy Adults by Dose and Sex
NCT06686914 ·Status: RECRUITING ·Phase: PHASE1
-
THC Titration of High-Potency Cannabis Concentrates
NCT07105449 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Cerebellar Alterations in Individuals With a Cannabis Use Disorder
NCT02816034 ·Status: COMPLETED ·Phase: NA
-
Alcohol Use Disorder and Cannabidiol
NCT05613608 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Imaging Cannabinoid CB1 Receptors in Alcohol Dependence
NCT00816439 ·Status: COMPLETED
-
Clinical Intervention in Alcohol Use Disorder
NCT02168400 ·Status: COMPLETED ·Phase: NA